These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 16509581

  • 1. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties.
    Ronconi L, Marzano C, Zanello P, Corsini M, Miolo G, Maccà C, Trevisan A, Fregona D.
    J Med Chem; 2006 Mar 09; 49(5):1648-57. PubMed ID: 16509581
    [Abstract] [Full Text] [Related]

  • 2. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
    Ronconi L, Giovagnini L, Marzano C, Bettìo F, Graziani R, Pilloni G, Fregona D.
    Inorg Chem; 2005 Mar 21; 44(6):1867-81. PubMed ID: 15762713
    [Abstract] [Full Text] [Related]

  • 3. Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands.
    Casini A, Cinellu MA, Minghetti G, Gabbiani C, Coronnello M, Mini E, Messori L.
    J Med Chem; 2006 Sep 07; 49(18):5524-31. PubMed ID: 16942025
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands.
    Casini A, Diawara MC, Scopelliti R, Zakeeruddin SM, Grätzel M, Dyson PJ.
    Dalton Trans; 2010 Mar 07; 39(9):2239-45. PubMed ID: 20162197
    [Abstract] [Full Text] [Related]

  • 5. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
    Sun RW, Li CK, Ma DL, Yan JJ, Lok CN, Leung CH, Zhu N, Che CM.
    Chemistry; 2010 Mar 08; 16(10):3097-113. PubMed ID: 20162647
    [Abstract] [Full Text] [Related]

  • 6. A novel anticancer gold(III) dithiocarbamate compound inhibits the activity of a purified 20S proteasome and 26S proteasome in human breast cancer cell cultures and xenografts.
    Milacic V, Chen D, Ronconi L, Landis-Piwowar KR, Fregona D, Dou QP.
    Cancer Res; 2006 Nov 01; 66(21):10478-86. PubMed ID: 17079469
    [Abstract] [Full Text] [Related]

  • 7. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
    Garza-Ortiz A, den Dulk H, Brouwer J, Kooijman H, Spek AL, Reedijk J.
    J Inorg Biochem; 2007 Nov 01; 101(11-12):1922-30. PubMed ID: 17637477
    [Abstract] [Full Text] [Related]

  • 8. Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand.
    Maiore L, Cinellu MA, Michelucci E, Moneti G, Nobili S, Landini I, Mini E, Guerri A, Gabbiani C, Messori L.
    J Inorg Biochem; 2011 Mar 01; 105(3):348-55. PubMed ID: 21421122
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
    Lemke J, Pinto A, Niehoff P, Vasylyeva V, Metzler-Nolte N.
    Dalton Trans; 2009 Sep 21; (35):7063-70. PubMed ID: 20449149
    [Abstract] [Full Text] [Related]

  • 10. Gold(III) complexes as a new family of cytotoxic and antitumor agents.
    Marcon G, Messori L, Orioli P.
    Expert Rev Anticancer Ther; 2002 Jun 21; 2(3):337-46. PubMed ID: 12113057
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes.
    Giovagnini L, Ronconi L, Aldinucci D, Lorenzon D, Sitran S, Fregona D.
    J Med Chem; 2005 Mar 10; 48(5):1588-95. PubMed ID: 15743200
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.
    Calamai P, Carotti S, Guerri A, Mazzei T, Messori L, Mini E, Orioli P, Speroni GP.
    Anticancer Drug Des; 1998 Jan 10; 13(1):67-80. PubMed ID: 9474243
    [Abstract] [Full Text] [Related]

  • 13. Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancer chemotherapy.
    Kouodom MN, Boscutti G, Celegato M, Crisma M, Sitran S, Aldinucci D, Formaggio F, Ronconi L, Fregona D.
    J Inorg Biochem; 2012 Dec 10; 117():248-60. PubMed ID: 22877925
    [Abstract] [Full Text] [Related]

  • 14. Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties.
    Maiore L, Cinellu MA, Nobili S, Landini I, Mini E, Gabbiani C, Messori L.
    J Inorg Biochem; 2012 Mar 10; 108():123-7. PubMed ID: 22173093
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
    Wang S, Shao W, Li H, Liu C, Wang K, Zhang J.
    Eur J Med Chem; 2011 May 10; 46(5):1914-8. PubMed ID: 21392862
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives.
    Serratrice M, Cinellu MA, Maiore L, Pilo M, Zucca A, Gabbiani C, Guerri A, Landini I, Nobili S, Mini E, Messori L.
    Inorg Chem; 2012 Mar 05; 51(5):3161-71. PubMed ID: 22339487
    [Abstract] [Full Text] [Related]

  • 17. Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents.
    Wang X, Guo Z.
    Dalton Trans; 2008 Mar 28; (12):1521-32. PubMed ID: 18335133
    [Abstract] [Full Text] [Related]

  • 18. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
    Liu W, Bensdorf K, Proetto M, Abram U, Hagenbach A, Gust R.
    J Med Chem; 2011 Dec 22; 54(24):8605-15. PubMed ID: 22091836
    [Abstract] [Full Text] [Related]

  • 19. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
    Gabbiani C, Casini A, Kelter G, Cocco F, Cinellu MA, Fiebig HH, Messori L.
    Metallomics; 2011 Dec 22; 3(12):1318-23. PubMed ID: 21887452
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C, Pellei M, Colavito D, Alidori S, Lobbia GG, Gandin V, Tisato F, Santini C.
    J Med Chem; 2006 Dec 14; 49(25):7317-24. PubMed ID: 17149861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.